PL3625213T3 - Fumaran (+)-3-(2,3-difluorofenylo)-3-metoksypirolidyny, sposób jego wytwarzania i jego zastosowania - Google Patents

Fumaran (+)-3-(2,3-difluorofenylo)-3-metoksypirolidyny, sposób jego wytwarzania i jego zastosowania

Info

Publication number
PL3625213T3
PL3625213T3 PL18730980.2T PL18730980T PL3625213T3 PL 3625213 T3 PL3625213 T3 PL 3625213T3 PL 18730980 T PL18730980 T PL 18730980T PL 3625213 T3 PL3625213 T3 PL 3625213T3
Authority
PL
Poland
Prior art keywords
methoxypyrrolidine
difluorophenyl
fumarate
preparation
methoxypyrrolidine fumarate
Prior art date
Application number
PL18730980.2T
Other languages
English (en)
Polish (pl)
Inventor
Clas Sonesson
Maija BUKSA
Inese Reine
Original Assignee
Integrative Research Laboratories Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integrative Research Laboratories Sweden Ab filed Critical Integrative Research Laboratories Sweden Ab
Publication of PL3625213T3 publication Critical patent/PL3625213T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
PL18730980.2T 2017-05-19 2018-05-18 Fumaran (+)-3-(2,3-difluorofenylo)-3-metoksypirolidyny, sposób jego wytwarzania i jego zastosowania PL3625213T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP17171938 2017-05-19
EP17195451 2017-10-09
EP17207406 2017-12-14
EP18151428 2018-01-12
PCT/EP2018/063123 WO2018211080A1 (en) 2017-05-19 2018-05-18 (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine or pharmaceutically acceptable salts thereof, a process for preparation thereof and uses thereof

Publications (1)

Publication Number Publication Date
PL3625213T3 true PL3625213T3 (pl) 2023-07-17

Family

ID=62599537

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18730980.2T PL3625213T3 (pl) 2017-05-19 2018-05-18 Fumaran (+)-3-(2,3-difluorofenylo)-3-metoksypirolidyny, sposób jego wytwarzania i jego zastosowania

Country Status (9)

Country Link
US (3) US11078158B2 (enExample)
EP (1) EP3625213B1 (enExample)
JP (1) JP7126522B2 (enExample)
CN (1) CN110621659B (enExample)
DK (1) DK3625213T3 (enExample)
ES (1) ES2943252T3 (enExample)
FI (1) FI3625213T3 (enExample)
PL (1) PL3625213T3 (enExample)
WO (1) WO2018211080A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12275694B2 (en) * 2019-05-24 2025-04-15 Irl 790 Ab Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof
CA3180417A1 (en) * 2020-06-10 2021-12-16 Guillaume Dutheuil Synthesis of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid
CN117430540A (zh) * 2022-07-14 2024-01-23 上海艾力斯医药科技股份有限公司 一种吡咯烷化合物及其制备方法
WO2025003437A1 (en) 2023-06-28 2025-01-02 Integrative Research Laboratories Sweden Ab A pharmaceutical composition comprising a fumaric acid salt of (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0586229A1 (en) * 1992-09-01 1994-03-09 Zeneca Limited 3-Hydroxy-3-(subst-akyl)-pyrrolidines as 5-lipoxygenase inhibitors
EP1582524B1 (en) 2004-04-02 2008-08-13 Ludwig Maximilians Universität Method of preparing organomagnesium compounds
AU2008258599B2 (en) * 2007-06-05 2013-06-13 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
WO2010058019A1 (en) * 2008-11-24 2010-05-27 Nsab, Filial Af Neurosearch Sweden Ab, Sverige 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
CN106957252B (zh) * 2014-11-19 2019-11-19 连云港恒运药业有限公司 一种质子泵抑制剂中间体及其制备方法

Also Published As

Publication number Publication date
US20240400505A1 (en) 2024-12-05
DK3625213T3 (da) 2023-04-24
JP7126522B2 (ja) 2022-08-26
CN110621659A (zh) 2019-12-27
US20210317081A1 (en) 2021-10-14
EP3625213A1 (en) 2020-03-25
WO2018211080A1 (en) 2018-11-22
CN110621659B (zh) 2023-02-28
US11078158B2 (en) 2021-08-03
CA3064136A1 (en) 2018-11-22
JP2020520936A (ja) 2020-07-16
EP3625213B1 (en) 2023-03-08
US12091384B2 (en) 2024-09-17
US20200024231A1 (en) 2020-01-23
FI3625213T3 (fi) 2023-05-29
ES2943252T3 (es) 2023-06-12

Similar Documents

Publication Publication Date Title
PT3660045T (pt) Polipéptido, processo para a sua produção e utilização
IL275272A (en) METHOD FOR MANUFACTURING 5,5-DI-META-5,4- DIHYDROISOXAZOLE
SI3497081T1 (sl) Postopek za pripravo 4-amonij-2,2,6,6-tetraalkilpiperidinilnih soli
GB2577981B (en) Methods, products & Uses relating thereto
ZA201906079B (en) Novel ester compounds, method for the production thereof and use thereof
ZA201801815B (en) Process for the synthesis of izm-2 zeolite in the presence of a template, 1,6-bis(methylpiperidinium)hexane dihydroxide
HUE052049T2 (hu) Kristályos 2-fluor-3-nitrotoluol és eljárás annak elõállítására
SG11202000431PA (en) 1,8-naphthyridinone compounds and uses thereof
ZA201905065B (en) Novel ester compounds, method for the production thereof and use thereof
GB201813648D0 (en) Methods, products & uses relating thereto
SI3515918T1 (sl) Postopek za pripravo 2-ekso-(2-metilbenziloksi)-1-metil-4-izopropil-7- oksabiciklo(2.2.1)heptana
GB2550399B (en) A novel form of sulfentrazone, a process for its preparation and use the same
DK3625213T3 (da) (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine fumarate, a process for its preparation and uses thereof
EP3398943A4 (en) Method for producing 1,2,3,5,6-pentathiepane
IL268266A (en) Process for preparing 2-exo-(2-methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[1.2.2]heptane
LT3592723T (lt) 3,3,3-trifluorprop-1-eno gavimo būdas
IL269269A (en) Process for preparing 2-exo-(2-methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane
GB201912016D0 (en) Methods, products & uses relating thereto
IL271148A (en) Process for preparing 4,3-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide
SG11202107896WA (en) A process for preparing soymilk, soymilk as prepared and the use thereof
PL3105243T3 (pl) Pochodne 2',3'-dideoksy-5-fluorourydyny, sposób ich wytwarzania i zastosowanie
GB201722014D0 (en) Analgesic 2,4,6-trinitro-3,3-dimethyl-5-tert-butylbenzene production plant
GB201722269D0 (en) 1,2-benzisothiazolin-3-one production plant
GB201722196D0 (en) N, N'-nickel di-n-butyldithiocarbamate production plant
IL291634A (en) Process for the preparation of 1,1'-disulfandylbis(4-fluoro-2-methyl-5-nitrobenzene)